Katarina Chroma

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Advanced Cancer

Hodgkin Lymphoma

Top Venues

Nature communications

International journal of molecular sciences

Cell death and differentiation

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Zuzana Machacova, Katarina Chroma, David Lukac, Iva Protivankova, Pavel Moudry
DNA polymerase α-primase facilitates PARP inhibitor-induced fork acceleration and protects BRCA1-deficient cells against ssDNA gaps. Nature communications 15 (1) (2024)
Zuzana Machacova, Katarina Chroma, David Lukac, Iva Protivankova, Pavel Moudry
DNA polymerase α-primase facilitates PARP inhibitor-induced fork acceleration and protects BRCA1-deficient cells against ssDNA gaps. Nature communications 15 (1) (2024)
Zuzana Machacova, Katarina Chroma, David Lukac, Iva Protivankova, Pavel Moudry
DNA polymerase α-primase facilitates PARP inhibitor-induced fork acceleration and protects BRCA1-deficient cells against ssDNA gaps. Nature communications 15 (1) (2024)
Zuzana Machacova, Katarina Chroma, David Lukac, Iva Protivankova, Pavel Moudry
DNA polymerase α-primase facilitates PARP inhibitor-induced fork acceleration and protects BRCA1-deficient cells against ssDNA gaps. Nature communications 15 (1) (2024)
Tereza Buchtova, David Lukac, Zdenek Skrott, Katarina Chroma, Jiri Bartek, Martin Mistrik
Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics. International journal of molecular sciences 24 (3) (2023)
Tereza Buchtova, David Lukac, Zdenek Skrott, Katarina Chroma, Jiri Bartek, Martin Mistrik
Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics. International journal of molecular sciences 24 (3) (2023)
Tereza Buchtova, David Lukac, Zdenek Skrott, Katarina Chroma, Jiri Bartek, Martin Mistrik
Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics. International journal of molecular sciences 24 (3) (2023)
Katarina Chroma, Zdenek Skrott, Jan Gursky, Jaroslav Bacovsky, Pavel Moudry, Tereza Buchtova, Martin Mistrik, Jiri Bartek
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment. Cell death & disease 13 (3) (2022)
Pavel Moudry, Katarina Chroma, Sladana Bursac, Sinisa Volarevic, Jiri Bartek
RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis. Cell death and differentiation (2021)